help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckers, A.
Right arrow Articles by Willems, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckers, A.
Right arrow Articles by Willems, P. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*Genetics Home Reference

Journal of Clinical Endocrinology & Metabolism, Vol 79, 1498-1502, Copyright © 1994 by Endocrine Society

ARTICLES

Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome

A Beckers, R Abs, E Reyniers, K De Boulle, A Stevenaert, FR Heller, G Kloppel, M Meurisse and PJ Willems
Department of Endocrinology, University of Liege, Belgium.

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant inherited disorder characterized by nodular proliferation of the parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas, and the neuroendocrine cell system of the gut. Loss of the putative tumor suppressor effect of the MEN1 gene is probably responsible for the development of MEN1-associated tumors. We report here a genetic study of a female MEN1 patient with the association of nodular hyperplasia of two parathyroid glands, an insulinoma, multiple duodenal gastrinomas, a prolactinoma, and a gastric carcinoid. We performed loss of heterozygosity (LOH) studies of chromosome 11 on all affected tissues except the insulinoma. Allelic losses of chromosome 11 were detected in several tumors, but the chromosomal regions of LOH were different, suggesting that different somatic mutational events are involved in the pathogenesis of these tumors. LOH of chromosome 11 was also detected in the prolactinoma of this patient, which indicates that the MEN1 gene has a tumor suppressor effect in the pituitary.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
A. Falchetti, A. Morelli, A. Amorosi, F. Tonelli, S. Fabiani, V. Martineti, R. Castello, L. Furlani, and M. L. Brandi
Allelic Loss in Parathyroid Tumors from Individuals Homozygous for Multiple Endocrine Neoplasia Type 1
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2278 - 2282.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Shimon and S. Melmed
Pituitary Tumor Pathogenesis
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1675 - 1681.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Q. Dong, L. V. Debelenko, S. C. Chandrasekharappa, M. R. Emmert-Buck, Z. Zhuang, S. C. Guru, P. Manickam, M. Skarulis, I. A. Lubensky, L. A. Liotta, et al.
Loss of Heterozygosity at 11q13: Analysis of Pituitary Tumors, Lung Carcinoids, Lipomas, and Other Uncommon Tumors in Subjects with Familial Multiple Endocrine Neoplasia Type 1
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1416 - 1420.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society